CSO Jan Stenvang will present data on SCO-101 and endocrine resistance in breast cancer at the 13th Annual EORTC PathoBiology Group Meeting, Hamburg, Germany, September 13-15, 2018. EORTC (European Organisation for Research and Treatment of Cancer) is an independent, non-profit cancer research organisation, with the mission to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients.